Where it comes from
- Made in
- The same neurons as galanin; the galanin precursor is also transcribed in skin keratinocytes
- Sent out by
- With galanin
- Acts on
- Spinal cord reflexes
- Fungi (Candida) in the laboratory
What it does
In medicine
- No medicine copies it, and no clinical laboratory measures it
- Nothing has been built on it because there is nothing to aim at: its effects are described by what they do rather than by what they bind 3
Beyond the body’s own use
- Nothing containing it is in trials, approved or obtainable outside the laboratory
- Its one activity galanin does not share is antifungal: fragments of GMAP slowed the growth of several non-albicans Candida species in culture 2
- What is unknown is whether the brain uses it at all. The spinal effects are seen with injected fragments rather than the whole 59-residue peptide, and no animal has been made that keeps galanin and loses GMAP, because one gene makes both 1
Sources
- Xu et al., Fragments of galanin message-associated peptide modulate the spinal flexor reflex in rat, European Journal of Pharmacology 1996
- Holub et al., Effects of galanin message-associated peptide against non-albicans Candida strains, International Journal of Antimicrobial Agents 2011
- Lang et al., Physiology, signalling and pharmacology of galanin peptides and receptors, Pharmacological Reviews 2015
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.